Journal article icon

Journal article

Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer.

Abstract:

BACKGROUND: Granulocyte-colony stimulating factor (G-CSF) reduces the risk of severe neutropenia associated with chemotherapy, but its cost implications following chemotherapy are unknown. OBJECTIVE: Our objective was to examine associations between G-CSF use and medical costs after initial adjuvant chemotherapy in early-stage (stage I-III) breast cancer (ESBC). METHODS: Women diagnosed with ESBC from 1999 to 2005, who had an initial course of chemotherapy beginning within 180 days of diagno...

Expand abstract

Actions


Access Document


Authors


Expand authors...
Journal:
PharmacoEconomics
Volume:
30
Issue:
2
Pages:
103-118
Publication date:
2012-02-05
DOI:
EISSN:
1179-2027
ISSN:
1170-7690
URN:
uuid:1e4492fa-727e-414a-acdf-c0f2b4757dcd
Source identifiers:
359099
Local pid:
pubs:359099

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP